Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.

  • Authors : Johnson H; Olympia Diagnostics, Inc., Sunnyvale, CA, USA.; Guo J

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*urine ; Early Detection of Cancer/Early Detection of Cancer/Early Detection of Cancer/*methods ; Prostate-Specific Antigen/Prostate-Specific Antigen/Prostate-Specific Antigen/*urine

  • Source: BMC medicine [BMC Med] 2020 Dec 01; Vol. 18 (1), pp. 376. Date of Electronic Publication: 2020 Dec 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

×
Academic Journal

Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone.

  • Authors : Liu J; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Dong B

Subjects: Prostate-Specific Antigen/Prostate-Specific Antigen/Prostate-Specific Antigen/*analysis ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*diagnosis; Aged

  • Source: Scientific reports [Sci Rep] 2020 Mar 20; Vol. 10 (1), pp. 5157. Date of Electronic Publication: 2020 Mar 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Rapidly progressing malignant phyllodes tumor of the prostate with normal prostate-specific antigen levels: A case report.

  • Authors : Zhang X; Department of Pathology, Jiujiang University Clinical Medical College, Jiujiang, China.; Hu J

Subjects: Phyllodes Tumor/Phyllodes Tumor/Phyllodes Tumor/*diagnostic imaging ; Prostate-Specific Antigen/Prostate-Specific Antigen/Prostate-Specific Antigen/*analysis ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*diagnostic imagingPhyllodes Tumor of the Prostate

  • Source: Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2020 Feb; Vol. 63 (Supplement), pp. S50-S52.Publisher: Medknow Country of Publication: India NLM ID: 7605904 Publication Model: Print Cited Medium: Internet ISSN: 0974-5130 (Electronic)

Record details

×
Academic Journal

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.

  • Authors : Wang H; Department of Urology, Chinese PLA General Hospital/PLA Medical School, Beijing, 100853, People's Republic of China.; Gu L

Subjects: Leukocyte Count* ; Lymphocytes* ; Neutrophils*

  • Source: BMC cancer [BMC Cancer] 2017 Sep 06; Vol. 17 (1), pp. 629. Date of Electronic Publication: 2017 Sep 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.

  • Authors : Shen P; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.; Zhao J

Subjects: Nomograms*; Prostate-Specific Antigen/Prostate-Specific Antigen/Prostate-Specific Antigen/*analysis ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*diagnosis

  • Source: Andrology [Andrology] 2017 May; Vol. 5 (3), pp. 548-555.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101585129 Publication Model: Print Cited Medium: Internet ISSN: 2047-2927

Record details

×
Academic Journal

Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.

  • Authors : Barber NJ; Department of Urology, Frimley Park Hospital, Surrey, UK. ; Zhang X

Subjects: Anticarcinogenic Agents/Anticarcinogenic Agents/Anticarcinogenic Agents/*pharmacology ; Carotenoids/Carotenoids/Carotenoids/*pharmacology ; DNA, Neoplasm/DNA, Neoplasm/DNA, Neoplasm/*biosynthesis

  • Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2006; Vol. 9 (4), pp. 407-13. Date of Electronic Publication: 2006 Sep 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.

  • Authors : Liu C; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Photothermal Therapy*/Photothermal Therapy*/Photothermal Therapy*/methods ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 03; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

  • Authors : Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China.; Wang Z

Subjects: Goserelin*/Goserelin*/Goserelin*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

  • Authors : Wang J; Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, 832000, Xinjiang, China.; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, 832000, Xinjiang, China.

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Animals

  • Source: BMC cancer [BMC Cancer] 2024 Jan 15; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2024 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.

  • Authors : Zhang H; Department of Urology, The Second People's Hospital of Kunshan, Kunshan, Jiangsu, China.; You Z

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Humans

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Oct; Vol. 11 (10), pp. e1061.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  110 results for ""Zhang X""